Pharmacokinetics of protein c and antithrombin in the fetal Lamb: A model to predict human neonatal replacement dosing

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: The preterm infant is at risk for consumptive coagulopathy and thrombosis du: 3.86 h (95% CI: 3.35-4.36) and 11.9 h (95% CI: 10.9-12.9) in the singletons and ewes, respectively. All PC parameters were significantly different for twins compared to ewes. Conclusions: AT and PC show decreased recovery and t in the fetal lamb. These data can be used to estimate dosing for human neonates in comparison with human adult dosing recommendations. Copyright © 2008 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Manco-Johnson, M. J., Hacker, M. R., Jacobson, L. J., & Hay, W. W. (2009). Pharmacokinetics of protein c and antithrombin in the fetal Lamb: A model to predict human neonatal replacement dosing. Neonatology, 95(4), 279–285. https://doi.org/10.1159/000178025

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free